![A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis - Lee - 2023 - The FEBS Journal - Wiley Online Library A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis - Lee - 2023 - The FEBS Journal - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/c416b6c3-ed6d-48e4-b362-0126e575f8d7/febs.v290.11.cover.jpg)
A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis - Lee - 2023 - The FEBS Journal - Wiley Online Library
![Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations | eLife Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations | eLife](https://iiif.elifesciences.org/lax/55279%2Felife-55279-fig4-v2.tif/full/1500,/0/default.jpg)
Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations | eLife
![A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis - Lee - 2023 - The FEBS Journal - Wiley Online Library A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis - Lee - 2023 - The FEBS Journal - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/cd4ef209-26a1-4f4e-9f76-0338625bcbaa/febs16442-fig-0004-m.jpg)
A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis - Lee - 2023 - The FEBS Journal - Wiley Online Library
![Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations | eLife Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations | eLife](https://iiif.elifesciences.org/lax/55279%2Felife-55279-fig5-v2.tif/full/1500,/0/default.jpg)
Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations | eLife
![A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis - Lee - 2023 - The FEBS Journal - Wiley Online Library A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis - Lee - 2023 - The FEBS Journal - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/f2d080fd-e068-43c7-9ce0-f667dfc0f814/febs16442-fig-0001-m.jpg)
A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis - Lee - 2023 - The FEBS Journal - Wiley Online Library
![Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations | eLife Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations | eLife](https://iiif.elifesciences.org/lax/55279%2Felife-55279-fig9-v2.tif/full/1500,/0/default.jpg)
Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations | eLife
![A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis - Lee - 2023 - The FEBS Journal - Wiley Online Library A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis - Lee - 2023 - The FEBS Journal - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/400535ec-a092-4f5c-ab48-0121dca4ec97/febs16442-fig-0003-m.jpg)
A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis - Lee - 2023 - The FEBS Journal - Wiley Online Library
![Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations | eLife Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations | eLife](https://iiif.elifesciences.org/lax/55279%2Felife-55279-fig6-v2.tif/full/1500,/0/default.jpg)
Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations | eLife
Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutat
![A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis - Lee - 2023 - The FEBS Journal - Wiley Online Library A recent update on small‐molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry‐based proteomic analysis - Lee - 2023 - The FEBS Journal - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/aceddbdd-b5c9-4bdc-8b35-df98fd83aae8/febs16442-fig-0002-m.jpg)